| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dustin Y Yoon, Christopher A Rippel, Andrew J Kobets, Christina M Morris, Jennifer E Lee, Phillip N Williams, Dana D Bridges, David J Vandenbergh, Yin Y Shugart, Harvey S Singe. Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 144B. issue 5. 2007-08-30. PMID:17171650. |
in this protocol, dopaminergic polymorphisms were examined for associations with ts and attention-deficit hyperactivity disorder (adhd). |
2007-08-30 |
2023-08-12 |
Not clear |
| James M Swanso. Role of executive function in ADHD. The Journal of clinical psychiatry. vol 64 Suppl 14. 2007-08-27. PMID:14658934. |
adhd is commonly treated with behavioral therapy and noradrenergic and dopaminergic pharmacotherapy with psychostimulants such as methylphenidate and dextroamphetamine. |
2007-08-27 |
2023-08-12 |
Not clear |
| Rosalind J Neuman, Elizabeth Lobos, Wendy Reich, Cynthia A Henderson, Ling-Wei Sun, Richard D Tod. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biological psychiatry. vol 61. issue 12. 2007-08-23. PMID:17157268. |
prenatal smoking exposure and dopaminergic genotypes interact to cause a severe adhd subtype. |
2007-08-23 |
2023-08-12 |
human |
| Michael A van der Kooij, Jeffrey C Glenno. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neuroscience and biobehavioral reviews. vol 31. issue 4. 2007-08-16. PMID:17316796. |
while the involvement of dopamine (da) in adhd has been established, the evaluation of rodent models of adhd particularly with respect to dopaminergic systems is attempted here. |
2007-08-16 |
2023-08-12 |
mouse |
| Jonathan Mill, Terje Sagvolden, Philip Asherso. Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains. Behavioral and brain functions : BBF. vol 1. 2007-07-26. PMID:16356184. |
human genetic studies have found associations between several dopaminergic genes and both adhd and depression. |
2007-07-26 |
2023-08-12 |
human |
| Andreas J Fallgatter, Klaus Peter Lesc. 22q11.2 deletion syndrome as a natural model for COMT haploinsufficiency-related dopaminergic dysfunction in ADHD. The international journal of neuropsychopharmacology. vol 10. issue 3. 2007-07-20. PMID:16848928. |
22q11.2 deletion syndrome as a natural model for comt haploinsufficiency-related dopaminergic dysfunction in adhd. |
2007-07-20 |
2023-08-12 |
Not clear |
| Benjamin Charles Campbell, Dan Eisenber. Obesity, attention deficit-hyperactivity disorder and the dopaminergic reward system. Collegium antropologicum. vol 31. issue 1. 2007-07-20. PMID:17600916. |
detailed consideration suggests that dopaminergic changes in the prefrontal cortex among individuals with the adhd subtype attention deficit disorder (add) may increase their risk for obesity. |
2007-07-20 |
2023-08-12 |
Not clear |
| Terje Sagvolde. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD). Behavioral and brain functions : BBF. vol 2. 2007-07-19. PMID:17173664. |
there is no biological marker, but there is considerable evidence to suggest that adhd behavior is associated with poor dopaminergic and noradrenergic modulation of neuronal circuits that involve the frontal lobes. |
2007-07-19 |
2023-08-12 |
rat |
| Shih-Jen Tsa. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Medical hypotheses. vol 68. issue 4. 2007-07-18. PMID:16919891. |
drawing on findings from studies into the drugs for adhd relating to central bdnf expression, hyperactivity in bdnf knockout mice, bdnf effects in midbrain dopaminergic function and the close association between bdnf and the dopamine transporter (an important molecule for adhd pathogenesis), it is proposed here that decreased central bdnf, particularly in the midbrain region, may play an important role in the pathogenesis adhd. |
2007-07-18 |
2023-08-12 |
mouse |
| M Kopecková, I Paclt, P Goet. Polymorphisms of dopamine-beta-hydroxylase in ADHD children. Folia biologica. vol 52. issue 6. 2007-06-22. PMID:17184598. |
dysfunction or imbalance between the dopaminergic and noradrenergic systems of neurotransmitters can play a key role in the adhd pathophysiology. |
2007-06-22 |
2023-08-12 |
human |
| Júlia P Genro, Cristian Zeni, Guilherme V Polanczyk, Tatiana Roman, Luis A Rohde, Mara H Hut. A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 144B. issue 2. 2007-04-11. PMID:17044101. |
the dopamine transporter (dat) plays a key role in the regulation of dopaminergic neurotransmission and is also the major site of action for methylphenidate which is one of the main drugs used to treat attention deficit hyperactivity disorder (adhd). |
2007-04-11 |
2023-08-12 |
Not clear |
| Neil Easton, Carolyn Steward, Fiona Marshall, Kevin Fone, Charles Marsde. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology. vol 52. issue 2. 2007-04-10. PMID:17020775. |
these results identify distinct pharmacological action by the amphetamine isomers on dopaminergic and noradrenergic neurotransmission, which may impact on their therapeutic effects in the treatment of adhd. |
2007-04-10 |
2023-08-12 |
rat |
| Emil F Coccaro, Sharon L Hirsch, Mark A Stei. Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects. Psychiatry research. vol 149. issue 1-3. 2007-04-10. PMID:17113158. |
based on the therapeutic action of dopaminergic agents in treating attention deficit hyperactivity disorder (adhd), adhd symptoms may be related to a reduction in central dopaminergic activity. |
2007-04-10 |
2023-08-12 |
human |
| Emil F Coccaro, Sharon L Hirsch, Mark A Stei. Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects. Psychiatry research. vol 149. issue 1-3. 2007-04-10. PMID:17113158. |
we tested the hypothesis that dopaminergic activity, as reflected by plasma homovanillic acid (phva), may be related to dimensional aspects of adhd in adults. |
2007-04-10 |
2023-08-12 |
human |
| Emil F Coccaro, Sharon L Hirsch, Mark A Stei. Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects. Psychiatry research. vol 149. issue 1-3. 2007-04-10. PMID:17113158. |
consistent with the dopaminergic dysfunction hypothesis of adhd and of cognitive function, phva concentrations were correlated with childhood history of adhd symptoms in general and with history of "learning problems" in non-adhd psychiatric patients and controls. |
2007-04-10 |
2023-08-12 |
human |
| Anna Migdalska, Magdalena Nawara, Jerzy Bal, Tadeusz Mazurcza. [Attention deficit hyperactivity disorder (ADHD)--molecular and genetic aspects]. Medycyna wieku rozwojowego. vol 10. issue 1 Pt 2. 2007-03-21. PMID:17028398. |
these analyses and also investigations on animal models of disease suggest that mutations in genes involved in dopaminergic, serotonergic and adrenergic systems are likely to be responsible for adhd. |
2007-03-21 |
2023-08-12 |
Not clear |
| Agnieszka Słopién, Monika Dmitrzak-Weglarz, Filip Rybakowski, Andrzej Rajewski, Joanna Hause. [Genetic background of ADHD: population studies, genes of the catecholamine system]. Psychiatria polska. vol 40. issue 1. 2007-03-20. PMID:16756025. |
one of the adhd predisposing factors is dopaminergic neurotransmission abnormality. |
2007-03-20 |
2023-08-12 |
Not clear |
| Agnieszka Słopień, Monika Dmitrzak-Weglarz, Filip Rybakowski, Andrzej Rajewski, Joanna Hause. [Genetic background of ADHD: genes of the serotonergic system, other candidate genes, endophenotype]. Psychiatria polska. vol 40. issue 1. 2007-03-20. PMID:16756026. |
biochemical and pharmacological studies reveal a connection between abnormalities of dopaminergic, adrenergic and serotonergic system and adhd. |
2007-03-20 |
2023-08-12 |
Not clear |
| C Mehler-Wex, P Riederer, M Gerlac. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotoxicity research. vol 10. issue 3-4. 2007-03-20. PMID:17197367. |
recent studies have strongly suggested that a disturbance of the dopaminergic system is also involved in the pathophysiology of adhd. |
2007-03-20 |
2023-08-12 |
mouse |
| C Mehler-Wex, P Riederer, M Gerlac. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotoxicity research. vol 10. issue 3-4. 2007-03-20. PMID:17197367. |
genetic studies have shown an association between adhd and genes involved in dopaminergic neurotransmission (for example the dopamine receptor genes drd4 and drd5, and the dat gene dat1). |
2007-03-20 |
2023-08-12 |
mouse |